FierceBiotech 2026年3月20日 Genentech antibody fails to boost muscle in rare diseases, raising questions for obesity trial
FierceBiotech 2026年3月20日 Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle
FierceBiotech 2026年3月20日 Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin
FierceBiotech 2026年3月19日 Lilly's obesity discovery partner Fauna sees weight loss potential in hibernating mammals
FierceBiotech 2026年3月19日 Phage-focused BiomX resets after adverse events derail pipeline, considers pivot to defense sector
FierceBiotech 2026年3月19日 Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’
FierceBiotech 2026年3月19日 Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trial
FierceBiotech 2026年3月19日 Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress
FierceBiotech 2026年3月18日 Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome
FierceBiotech 2026年3月18日 JenaValve's Trilogy valve secures FDA's 1st approval in aortic regurgitation